Page 122 - Read Online
P. 122

Webber et al                                                                                                                                                                            prostate cancer microenvironment

           We hope you enjoy this special issue of the Journal of   REFERENCES
           Cancer Metastasis and Treatment.
                                                              1.   Mason M. Getting better at treating prostate cancer: what clinicians
                                                                 should want from scientists. J Cancer Metastasis Treat 2017;3:271-7.
           DECLARATIONS                                       2.   Maitland NJ. Getting closer to prostate cancer patients: what
                                                                 scientists should want from clinicians. J Cancer Metastasis Treat
           Authors’ contribution                                 2017;3:262-70.
           Manuscript writting and revision: Webber JP, Pors K  3.   Pippione AC, Boschi D, Pors K, Oliaro-Bosso S, Lolli ML.
                                                                 Androgen-AR axis in primary and metastatic prostate cancer:
           Availability of data and materials                    chasing steroidogenic enzymes for therapeutic intervention. J Cancer
                                                                 Metastasis Treat 2017;3:328-61.
           Not applicable.                                    4.   Morgan R, Pandha HS. HOX transcription factors and the prostate
                                                                 tumor microenvironment. J Cancer Metastasis Treat 2017;3:278-87.
           Financial support and sponsorship                  5.   Falconer RA, Loadman PM. Membrane-type matrix metalloproteinases:
           None.                                                 expression, roles in metastatic prostate cancer progression and oppor-
                                                                 tunities for drug targeting. J Cancer Metastasis Treat 2017;3:315-27.
           Conflicts of interest                              6.   Shephard AP, Yeung V, Clayton A, Webber JP. Prostate cancer
                                                                 exosomes as modulators of the tumor microenvironment. J Cancer
           The authors declare there are no conflicts of interest.  Metastasis Treat 2017;3:288-301.
                                                              7.   Frame FM, Noble AR, Klein S, Walker HF, Suman R, Kasprowicz
           Ethical approval and consent to participate           R, Mann VM, Simms MS, Maitland NJ. Tumor heterogeneity and
           Not applicable.                                       therapy resistance - implications for future treatments of prostate
                                                                 cancer. J Cancer Metastasis Treat 2017;3:302-14.
           Consent for publication                            8.   McKenna DJ, Errington R, Pors K. Current challenges and oppor-
           Not applicable.                                       tunities in treating hypoxic prostate tumors. J Cancer Metastasis
                                                                 Treat 2018;4:11.
                                                              9.   Ibrahim AIM, Sadiq M, Frame FM, Maitland NJ, Pors K. Expression
           Copyright                                             and regulation of aldehyde dehydrogenases in prostate cancer. J
           © The Author(s) 2018.                                 Cancer Metastasis Treat 2018;4:44.













































                           Journal of Cancer Metastasis and Treatment ¦ Volume 4 ¦ Aug 21, 2018            3
   117   118   119   120   121   122   123   124   125   126   127